LivaNova PLC Excess Tax Benefit from Share-based Compensation, Financing Activities
LivaNova PLC (LIVN) reported Excess Tax Benefit from Share-based Compensation, Financing Activities of $2.06 million for the 12-month period ending 2016-12-31, per its 10-K filed 2017-03-01.
Discontinued › Notes › Compensation Related Costs
us-gaap:ExcessTaxBenefitFromShareBasedCompensationFinancingActivities · last filed 2017-03-01
- LivaNova PLC excess tax benefit from share-based compensation, financing activities for the quarter ending 2016-12-31 was $852.00K.
- LivaNova PLC excess tax benefit from share-based compensation, financing activities for the quarter ending 2016-09-30 was $339.00K, a 85.88% decline year-over-year.
- LivaNova PLC excess tax benefit from share-based compensation, financing activities for the quarter ending 2016-06-30 was $164.00K, a 68.40% decline year-over-year.
- LivaNova PLC excess tax benefit from share-based compensation, financing activities for the quarter ending 2016-03-31 was $705.00K, a 56.27% decline year-over-year.
- LivaNova PLC excess tax benefit from share-based compensation, financing activities for fiscal 2016 was $2.06M.
- LivaNova PLC excess tax benefit from share-based compensation, financing activities for fiscal 2015 was $4.75M, a 82.21% decline from fiscal 2014.
- LivaNova PLC excess tax benefit from share-based compensation, financing activities for fiscal 2014 was $26.68M, a 504.12% increase from fiscal 2013.
- LivaNova PLC excess tax benefit from share-based compensation, financing activities for fiscal 2013 was $4.42M.
| Period end | Excess Tax Benefit from Share-based Compensation, Financing Activities 3 month | Excess Tax Benefit from Share-based Compensation, Financing Activities 6 month | Excess Tax Benefit from Share-based Compensation, Financing Activities 8 month | Excess Tax Benefit from Share-based Compensation, Financing Activities 9 month | Excess Tax Benefit from Share-based Compensation, Financing Activities 12 month |
|---|---|---|---|---|---|
| 2016-12-31 | $852.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-01 | $1.19M derived: sum of 2 quarters · filed 2017-03-01 | $1.35M derived: sum of 3 quarters · filed 2017-03-01 | $2.06M 10-K · filed 2017-03-01 | |
| 2016-09-30 | $339.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-02 | $503.00K derived: sum of 2 quarters · filed 2016-11-02 | $1.21M 10-Q · filed 2016-11-02 | ||
| 2016-06-30 | $164.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-05 | $869.00K 10-Q · filed 2016-08-05 | |||
| 2016-03-31 | $705.00K 10-Q · filed 2016-05-09 | ||||
| 2015-12-31 | $3.05M 10-K · filed 2017-03-01 | ||||
| 2015-10-18 | $2.40M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-02 | $2.92M 10-Q · filed 2015-12-08 | $4.53M 10-Q · filed 2016-11-02 | ||
| 2015-07-24 | $519.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-05 | $2.13M 10-Q · filed 2016-08-05 | |||
| 2015-04-24 | $1.61M 10-Q · filed 2016-05-09 | $4.75M 10-K · filed 2017-03-01 | |||
| 2014-10-24 | $2.59M 10-Q · filed 2015-12-08 | ||||
| 2014-04-25 | $26.68M 10-K · filed 2017-03-01 | ||||
| 2013-04-26 | $4.42M 10-KT · filed 2016-03-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Integer Holdings Corp (ITGR) | United States | $4.289B | 25.17 |
| TransMedics Group, Inc. (TMDX) | United States | $2.911B | 15.17 |
| Axogen, Inc. (AXGN) | United States | $2.329B | -73.83 |
| BIOLIFE SOLUTIONS INC (BLFS) | United States | $1.887B | 23.80 |
| CONMED Corp (CNMD) | United States | $1.353B | 26.72 |
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |